Alps Advisors Inc
- SEC CIK
- 0001376113
- Latest filing
- Jul 29, 2026
AKBA holding history
Akebia Therapeutics, Inc. in every 13F filed by Alps Advisors Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AKBA overviewAll 13F holders of AKBAFull Q2 2026 holdings
- Shares (Q2 2026)
- 272,262
- Value
- $310.4K
- % of portfolio
- <0.1%
- Quarters held
- 5
- Since Q2 2025
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 272,262 | $310.4K | <0.1% | +54,192+24.9% | Added | Holders |
| Q1 2026 | 218,070 | $303.1K | <0.1% | +179+0.1% | Added | Holders |
| Q4 2025 | 217,891 | $350.8K | <0.1% | +91,830+72.8% | Added | Holders |
| Q3 2025 | 126,061 | $344.1K | <0.1% | −15,603−11.0% | Reduced | Holders |
| Q2 2025 | 141,664 | $515.7K | <0.1% | +141,664 | New | Holders |